Atlas Trials

Clinical Study of SARS-CoV-2 Vaccine in Metabolism-related Fatty Liver Disease

Clinical trial NCT05738707 · UNKNOWN

Trial details

NCT number
NCT05738707
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Status
UNKNOWN
Study type
OBSERVATIONAL
Metabolic Associated Fatty Liver Disease
Start date
2023-02-01
Primary completion
2026-01-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.